159 related articles for article (PubMed ID: 26640372)
1. Complex antithrombotic therapy: determinants of patient preference and impact on medication adherence.
Abraham NS; Naik AD; Street RL; Castillo DL; Deswal A; Richardson PA; Hartman CM; Shelton G; Fraenkel L
Patient Prefer Adherence; 2015; 9():1657-68. PubMed ID: 26640372
[TBL] [Abstract][Full Text] [Related]
2. Primary-care patients' trade-off preferences with regard to antidepressants.
Wouters H; Van Dijk L; Van Geffen EC; Gardarsdottir H; Stiggelbout AM; Bouvy ML
Psychol Med; 2014 Aug; 44(11):2301-8. PubMed ID: 24398071
[TBL] [Abstract][Full Text] [Related]
3. Methodologic evaluation of adaptive conjoint analysis to assess patient preferences: an application in oncology.
Pieterse AH; Stiggelbout AM; Marijnen CA
Health Expect; 2010 Dec; 13(4):392-405. PubMed ID: 20550594
[TBL] [Abstract][Full Text] [Related]
4. Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor-positive breast cancer.
Wouters H; Maatman GA; Van Dijk L; Bouvy ML; Vree R; Van Geffen EC; Nortier JW; Stiggelbout AM
Ann Oncol; 2013 Sep; 24(9):2324-9. PubMed ID: 23709173
[TBL] [Abstract][Full Text] [Related]
5. Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment.
Beusterien KM; Dziekan K; Flood E; Harding G; Jordan JC
Value Health; 2005; 8(4):453-61. PubMed ID: 16091022
[TBL] [Abstract][Full Text] [Related]
6. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Wilson L; Loucks A; Bui C; Gipson G; Zhong L; Schwartzburg A; Crabtree E; Goodin D; Waubant E; McCulloch C
J Neurol Sci; 2014 Sep; 344(1-2):80-7. PubMed ID: 25037284
[TBL] [Abstract][Full Text] [Related]
7. Understanding patient preferences for the treatment of lupus nephritis with adaptive conjoint analysis.
Fraenkel L; Bodardus S; Wittnik DR
Med Care; 2001 Nov; 39(11):1203-16. PubMed ID: 11606874
[TBL] [Abstract][Full Text] [Related]
8. Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment.
Pinto CA; Chua GN; Bridges JFP; Brookes E; Hyacinthe J; Tervonen T
Patient; 2022 Mar; 15(2):255-266. PubMed ID: 34569030
[TBL] [Abstract][Full Text] [Related]
9. Preference elicitation tool for abnormal uterine bleeding treatment: a randomized controlled trial.
Hess LM; Litwiller A; Byron J; Stutsman J; Kasper K; Learman LA
Patient; 2015 Apr; 8(2):217-27. PubMed ID: 25074354
[TBL] [Abstract][Full Text] [Related]
10. Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians.
Gregorian RS; Gasik A; Kwong WJ; Voeller S; Kavanagh S
J Pain; 2010 Nov; 11(11):1095-108. PubMed ID: 20452835
[TBL] [Abstract][Full Text] [Related]
11. Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.
Laba TL; Essue B; Kimman M; Jan S
Patient; 2015 Oct; 8(5):385-95. PubMed ID: 25404203
[TBL] [Abstract][Full Text] [Related]
12. Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer.
daCosta DiBonaventura M; Copher R; Basurto E; Faria C; Lorenzo R
Am Health Drug Benefits; 2014 Oct; 7(7):386-96. PubMed ID: 25525495
[TBL] [Abstract][Full Text] [Related]
13. Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care.
Ali M; Grogan S; Powell S; Staniford L; Nazir J; Landeira M; Covernton PJO; Jaggi A; Fatoye F; Holt M
Adv Ther; 2019 Nov; 36(11):3110-3122. PubMed ID: 31559603
[TBL] [Abstract][Full Text] [Related]
14. Preserving Self: Medication-Taking Practices and Preferences of Older Adults With Multiple Chronic Medical Conditions.
Vandermause R; Neumiller JJ; Gates BJ; David P; Altman M; Healey DJ; Benson P; Sunwold D; Burton G; Tuttle KR; Corbett CF
J Nurs Scholarsh; 2016 Nov; 48(6):533-542. PubMed ID: 27802372
[TBL] [Abstract][Full Text] [Related]
15. Adaptive Conjoint Analysis as individual preference assessment tool: feasibility through the internet and reliability of preferences.
Pieterse AH; Berkers F; Baas-Thijssen MC; Marijnen CA; Stiggelbout AM
Patient Educ Couns; 2010 Feb; 78(2):224-33. PubMed ID: 19581069
[TBL] [Abstract][Full Text] [Related]
16. Patient Preferences for Chronic Myeloid Leukemia Medication Regimen Attributes and their Potential Impact on Adherence: Results from a Multi-national Conjoint Study.
Hirji I; Grinspan J; Flood E; Chirovsky D; Devlen J; Wagner S; Davis C
J Health Econ Outcomes Res; 2014; 2(1):75-86. PubMed ID: 37664084
[No Abstract] [Full Text] [Related]
17. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.
Brett Hauber A; Fairchild AO; Reed Johnson F
Appl Health Econ Health Policy; 2013 Aug; 11(4):319-29. PubMed ID: 23637054
[TBL] [Abstract][Full Text] [Related]
18. Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.
Pettersen TR; Fridlund B; Bendz B; Nordrehaug JE; Rotevatn S; Schjøtt J; Norekvål TM;
Int J Nurs Stud; 2018 Dec; 88():16-24. PubMed ID: 30165236
[TBL] [Abstract][Full Text] [Related]
19. Perceived advantages and disadvantages of oral anticoagulants, and the trade-offs patients make in choosing anticoagulant therapy and adhering to their drug regimen.
Vaanholt MCW; Weernink MGM; von Birgelen C; Groothuis-Oudshoorn CGM; IJzerman MJ; van Til JA
Patient Educ Couns; 2018 Nov; 101(11):1982-1989. PubMed ID: 30001822
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of patients' preferences for osteoporosis medications and their attributes: the PREFER-International study.
Duarte JW; Bolge SC; Sen SS
Clin Ther; 2007 Mar; 29(3):488-503. PubMed ID: 17577470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
